HDAC9 and neoplasm: SS as an HDAC inhibitor can effectively inhibit over-activated HDAC, leading to tumor cell blockade, the enhancement of apoptosis and the promotion of cell cycle arrest, which are expected to provide a novel vision for the construction of next-generation HDAC inhibitors.